Company profile for Spark Therapeutics, Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Spark Therapeutics, a fully integrated, commercial company committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia, lysosomal storage disorders and neurodegenerative diseases. Founded in March 2013 as a result of the technology and know-how accumulated over two decades at Children’s Hospital of Philadelphia (CHOP), our investig...
At Spark Therapeutics, a fully integrated, commercial company committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia, lysosomal storage disorders and neurodegenerative diseases. Founded in March 2013 as a result of the technology and know-how accumulated over two decades at Children’s Hospital of Philadelphia (CHOP), our investigational therapies have the potential to provide long-lasting effects, dramatically and positively changing the lives of patients with conditions where no, or only palliative, therapies exist.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3737 Market Street Philadelphia, PA 19104
Telephone
Telephone
+1 215-220-9300
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Spark Lays Off 298 Employees
Spark Lays Off 298 Employees

07 Apr 2025

// BIOSPACE

https://www.biospace.com/job-trends/spark-therapeutics-cuts-298-employees-as-part-of-reorganization

BIOSPACE
07 Apr 2025

https://www.fiercepharma.com/pharma/roche-overhauls-spark-gene-therapy-unit-recording-24b-full-impairment

FIERCE PHRMA
11 Mar 2025

https://www.fiercebiotech.com/biotech/roche-mothballs-another-hemophilia-gene-therapy-under-spark-it-plans-debut-new-hematologic

FIERCE BIOTECH
18 Dec 2024

https://www.fiercebiotech.com/biotech/roche-pumps-brakes-pompe-axing-gene-therapy-after-assessing-competition

FIERCE BIOTECH
25 Jul 2024

https://endpts.com/spark-co-founder-launches-new-cns-gene-therapy-startup-latus-bio-with-54m/

Kyle LaHucik ENDPTS
02 May 2024

https://endpts.com/spark-lines-up-next-retinal-gene-therapy-pact-in-barcelona/

Kyle LaHucik ENDPTS
17 Oct 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty